Baocai Xing
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Camrelizumab, a patinib and radiotherapy in locally advanced, unresectable hepatocellular carcinoma: a phase 2 study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 09, 2026
Evolution of Aptamer Materials Maps Exosomal Surface Proteins at the Nano-Bio Interface.
Journal: Nano letters
Published: March 28, 2026
Radiomics and blood biomarkers for predicting efficacy of sintilimab plus lenvatinib in advanced hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: January 09, 2026
Planned Liver Stereotactic Body Radiotherapy for Residual Colorectal Cancer Liver Metastases After Surgery: A Single-Arm Retrospective Study.
Journal: Current oncology (Toronto, Ont.)
Published: April 09, 2025
Enhanced antitumor immunity of mRNA vaccines by bioorthogonal-like delayed activation of exogeneous STING.
Journal: Nature biotechnology
Published: April 04, 2025
Expert consensus regarding the clinical application of liver contrast-enhanced US with Sonazoid (Sonazoid CEUS).
Journal: International journal of surgery (London, England)
Published: March 25, 2025
Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition).
Journal: Hepatobiliary surgery and nutrition
Published: February 28, 2025
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial.
Journal: Signal transduction and targeted therapy
Published: January 18, 2025
Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition).
Journal: Bioscience trends
Published: December 25, 2024
Phase II trial of hepatic arterial infusion chemotherapy plus bevacizumab and toripalimab for advanced biliary tract cancers: efficacy, safety, and exploratory analysis.
Journal: Hepatobiliary surgery and nutrition
Published: August 22, 2024
Last Updated: 09/26/2026